VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis.
about
Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease.Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice.
P2860
VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@en
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@nl
type
label
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@en
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@nl
prefLabel
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@en
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis.
@nl
P2093
P2860
P1476
VBP15, a novel dissociative st ...... sulfonic acid-induced colitis
@en
P2093
Anthony D Sandler
Blythe C Dillingham
Jesse M Damsker
John M McCall
Karuna Panchapakesan
Laurie S Conklin
Soheil Sadri
P2860
P2888
P304
P356
10.1007/S00011-016-0956-8
P577
2016-06-03T00:00:00Z